Australian Patent Office Grants New Patent Covering Enlivex’s AllocetraTM Immunotherapy Treatment Nasdaq
Nes-Ziona, Israel, June 18, 2019– Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the Australian Patent.